Gastroduodenal mucosal defense

Current Opinion in Gastroenterology

Volumn 24, Issue 6, 2008, Pages 665-673

  Ham, Maggie ^b   Kaunitz, Jonathan D ^a,b  

^a VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^b ROSS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bicarbonate; Cyclooxygenase inhibitors; Duodenum; Leptin; Matrix metalloproteinase; Orexins; Stomach; Survivin

Indexed keywords

ALCOHOL; ATROPINE METHYL NITRATE; CAPSAICIN; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; ENTEROTOXIN; IBUPROFEN; INDOMETACIN; LEPTIN; LUMIRACOXIB; LUZINDOLE; MISOPROSTOL; MUCIN 1; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE; OREXIN; PROSTAGLANDIN E1 DERIVATIVE; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE; PROTON PUMP INHIBITOR; RABEPRAZOLE; RANITIDINE; REBAMIPIDE; SUCRALFATE; SURVIVIN; THIOREDOXIN 1; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; UNINDEXED DRUG;

ABDOMINAL PAIN; ANTIINFLAMMATORY ACTIVITY; BLOATING; CHRONIC GASTRITIS; CLINICAL TRIAL; DIARRHEA; DIGESTIVE SYSTEM INJURY; DIGESTIVE SYSTEM ULCER; DRUG SAFETY; DUODENUM SECRETION; EROSIVE GASTRITIS; ESCHERICHIA COLI; GASTROINTESTINAL MUCOSA; GASTROINTESTINAL SYMPTOM; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HOST RESISTANCE; HUMAN; NAUSEA; NONHUMAN; PEPTIC ULCER; REVIEW; STOMACH DISEASE; STOMACH ULCER;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BICARBONATES; DUODENAL DISEASES; DUODENUM; GASTRIC ACID; GASTRIC MUCINS; GASTRIC MUCOSA; HUMANS; MATRIX METALLOPROTEINASES; MICROTUBULE-ASSOCIATED PROTEINS; STOMACH DISEASES;

EID: 55749088977     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOG.0b013e328311cd93     Document Type: Review

References (50)

1. Dannhardt G, Kiefer W. Cyclooxygenase inhibitors: current status and future prospects. Eur J Med Chem 2001; 36:109-126.
2. Allen A, Flemström G. Gastroduodenal mucus bicarbonate barrier: protection against acid and pepsin. Am J Physiol Cell Physiol 2005; 288:C1-C19.
3. Hawkey CJ, Karrasch JA, Szczepanski L, et al. Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. Omeprazole versus Misoprostol for NSAID-induced Ulcer Management (OMNIUM) Study Group [see comments]. N Engl J Med 1998; 338:727-734.
4. Park SH, Cho CS, Lee OY, et al. Comparison of prevention of NSAID-induced gastrointestinal complications by rebamipide and misoprostol: a randomized, multicenter, controlled trial-STORM study. J Clin Biochem Nutr 2007; 40:148-155. Rebamipide is as effective as misoprostol in gastroprotection without the gastro-intestinal side effects.
5. Du Y, Li Z, Zhan X, et al. Anti-inflammatory effects of rebamipide according to helicobacter pylori status in patients with chronic erosive gastritis: a randomized sucralfate-controlled multicenter trial in China-STARS study. Dig Dis Sci 2008 [Epub ahead of print]. Rebamipide is superior to sucralfate in treating chronic erosive gastritis, regardless of H. pylori status.
6. Irani S, Krevsky B, Desipio J, et al. Rapid protection of the gastroduodenal mucosa against aspirin-induced damage by rabeprazole. Aliment Pharmacol Ther 2008; 27:498-503. Rabeprazole acts rapidly, with doses taken only 5 h prior to aspirin therapy decreasing gastroduodenal injury.
7. 4 in comparison to ranitidine.
8. Pilotto A, Seripa D, Franceschi M, et al. Genetic susceptibility to nonsteroidal anti-inflammatory drug-related gastroduodenal bleeding: role of cytochrome P450 2C9 polymorphisms. Gastroenterology 2007; 133:465-471. Patients with CYP2C9*1/*2 and CYP2C9*1/*3 genotype, as well as the CYP2C9*3 allele are at higher risk for NSAID-induced gastrointestinal bleeding.
9. Ham M, Kaunitz JD. Gastroduodenal defense. Curr Opin Gastroenterol 2007; 23:607-616.
10. Tan A, Nakamura H, Kondo N, et al. Thioredoxin-1 attenuates indomethacin-induced gastric mucosal injury in mice. Free Radie Res 2007; 41:861-869. Thioredoxin-1 acts as an antioxidant and regulates apoptosis, decreasing mucosal lesions in indomethacin treated mice.
11. Chiou SK, Tanigawa T, Akahoshi T, et al. Survivin: a novel target for indomethacin-induced gastric injury. Gastroenterology 2005; 128:63-73.
12. Chiou SK, Mandayam S. NSAIDs enhance proteasomic degradation of survivin, a mechanism of gastric epithelial cell injury and apoptosis. Biochem Pharmacol 2007; 74:1485-1495. Indomethacin downregulates survivin via ubiquitin proteasome pathway, and overexpression of survivin conferred greater resistance to indomethacin-induced mucosal injury.
13. cdc2 kinase and protects against ethanol-induced mucosal injury.
14. Gyires K, Zadori ZS, Shujaa N, et al. Analysis of the role of central and peripheral alpha2-adrenoceptor subtypes in gastric mucosal defense in the rat. Neurochem Int 2007; 51:289-296. CNS contributes to gastroprotection via a vagal mechanism.
15. Tarnawski A, Pai R, Deng X, et al. Aging gastropathy-novel mechanisms: hypoxia, up-regulation of multifunctional PTEN, and proapoptotic factors. Gastroenterology 2007; 133:1938-1947.
16. Zhang Y, Proenca R, Maffei M, et al. Positional cloning of the mouse obese gene and its human homologue. Nature 1994; 372:425-432.
17. Bado A, Levasseur S, Attoub S, et al. The stomach is a source of leptin. Nature 1998; 394:790-793.
18. Motawi TK, bd Elgawad HM, Shahin NN. Gastroprotective effect of leptin in indomethacin-induced gastric injury. J Biomed Sci 2008; 15:405-412. When indomethacin treated rats were pretreated with leptin, antioxidant activity, mucin, and tissue nitric oxide were increased, with decrease in gastric ulcer index and neutrophil infiltration.
19. Shahin M, Konturek JW, Pohle T, et al. Remodeling of extracellular matrix in gastric ulceration. Microsc Res Tech 2001; 53:396-408.
20. Lempinen M, Inkinen K, Wolff H, Ahonen J. Matrix metalloproteinases 2 and 9 in indomethacin-induced rat gastric ulcer. Eur Surg Res 2000; 32:169-176.
21. Pradeepkumar SL, Kundu P, Ganguly K, et al. Novel role of famotidine in downregulation of matrix metalloproteinase-9 during protection of ethanol-induced acute gastric ulcer. Free Radio Biol Med 2007; 43:280-299.
22. Swarnakar S, Mishra A, Ganguly K, Sharma AV. Matrix metalloproteinase-9 activity and expression is reduced by melatonin during prevention of ethanol-induced gastric ulcer in mice. J Pineal Res 2007; 43:56-64. Melatonin protects ethanol-induced injury by inhibiting TNFα, inhibiting proMMP-9 activity and upregulating tissue inhibitor of metalloproteinases (TIMP).
23. Garg P, Ravi A, Patel NR, et al. Matrix metalloproteinase-9 regulates MUC-2 expression through its effect on goblet cell differentiation. Gastroenterology 2007; 132:1877-1889. MUC-2 is the predominant secretory mucin in the intestinal mucus layer, which is inhibited by MMP-9. MMP-9 regulates goblet cell differentiation, thus modulating MUC-2.
24. McAuley JL, Linden SK, Png CW, et al. MUC1 cell surface mucin is a critical element of the mucosal barrier to infection. J Clin Invest 2007; 117:2313-2324. Muc-1 knockout mice became systemically infected when exposed to C.jejuni in the gastrointestinal tract. These mice also demonstrated increased apoptosis and sloughing of mucosal epithelium.
25. McGuckin MA, Every AL, Skene CD, et al. Muc1 mucin limits both Helico bacter pylori colonization of the murine gastric mucosa and associated gastritis. Gastroenteroiogy 2007; 133:1210-1218. Muc-1 knockout mice had significantly more colonization by H. pylori, with development of atrophic gastritis and loss of parietal cells.
26. Holzer P. Efferent-like roles of afferent neurons in the gut: blood flow regulation and tissue protection. Auton Neurosci 2006; 125:70-75.
27. Lee IO, Lee KH, Pyo JH, et al. Anti-inflammatory effect of capsaicin in Helico bacter pylori-infected gastric epithelial cells. Helicobacter 2007; 12:510-517. Capsaicin blocks H. pylori-induced inflammatory cytokine production.
28. 1 cell cycle arrest in T cells, likely causing persistent infection in gastric mucosa.
29. Montecucco C, de BM, Papini E, Zoratti M. Helicobacter pylori vacuolating cytotoxin: cell intoxication and anion-specific channel activity. Curr Top Microbiol Immunol 2001; 257:113-129.
30. 1 cell cycle arrest and apoptosis in human gastric epithelial cells.
31. Hofman V, Lassalle S, Selva E, et al. Involvement of mast cells in gastritis caused by Helicobacter pylori: a potential role in epithelial cell apoptosis. J Clin Pathol 2007; 60:600-607. Mast cells are present in high quantities in human H. pylori-infected gastric tissue with elevated proapoptotic proteins and decreased antiapoptotic proteins, suggesting that mast cells may be involved in gastric epithelial cell apoptosis.
32. Bussiere FI, Chaturvedi R, Cheng Y, et al. Spermine causes loss of innate immune response to Helicobacter pylori by inhibition of inducible nitric-oxide synthase translation. J Biol Chem 2005; 280:2409-2412.
33. Fu S, Ramanujam KS, Wong A, et al. Increased expression and cellular localization of inducible nitric oxide synthase and cyclooxygenase 2 in Helicobacter pylori gastritis. Gastroenteroiogy 1999; 116:1319-1329.
34. Chaturvedi R, Asim M, Lewis ND, et al. L-arginine availability regulates inducible nitric oxide synthase-dependent host defense against Helicobacter pylori. Infect Immun 2007; 75:4305-4315. Nitric oxide produced by iNOS killed H. pylori in vitro but not in vivo, likely because in-vivo levels of L-Arg (the rate limiting step for iNOS translation) are too low to destroy H. pylori.
35. Rad R, Brenner L, Krug A, et al. Toll-like receptor-dependent activation of antigen-presenting cells affects adaptive immunity to Helicobacter pylori. Gastroenterology 2007; 133:150-163. TLRs activate dendritic cells via a Myd88-dependent pathway.
36. West SD, Suliburk JW, Helmer KS, Mercer DW. Cyclooxygenase-1 suppresses lipopolysaccharide-induced changes in rat gastric inducible nitric oxide synthase. Crit Care Med 2008; 36:572-579. COX-1 is important in gastrointestinal dysfunction and sepsis as it decreases iNOS in the rat stomach and decreases susceptibility to mucosal injury.
37. 2 also increased VEGF and angiogenesis.
38. 2 likely protecting gastric mucosa from early microscopic injuries and preventing spread of the damage.
39. 2/IP receptors are respon-sible for luminal alkalinization in gastric mucosal injury.
40. Hawkey CJ, Weinstein WM, Smalley W, et al. Effect of risk factors on complicated and uncomplicated ulcers in the TARGET lumiracoxib outcomes study. Gastroenterology 2007; 133:57-64. Large randomized prospective outcomes study comparing lumiracoxib with various NSAIDs found lumiracoxib to be safer with fewer gastrointestinal complications, except in patients using concomitant aspirin.
41. Ray WA, Chung CP, Stein CM, et al. Risk of peptic ulcer hospitalizations in users of NSAIDs with gastroprotective cotherapy versus coxibs. Gastroenterology 2007; 133:790-798. Patients taking a coxib with a PPI had the least peptic ulcer hospitalizations, while taking a coxib was equivalent to taking a combination of an NSAID with a PPI.
42. Garcia Rodriguez LA, Barreales TL. Risk of upper gastrointestinal complications among users of traditional NSAIDs and COXIBs in the general population. Gastroenterology 2007; 132:498-506.
43. Bengtsson MW, Jedstedt G, Flemström G. Duodenal bicarbonate secretion in rats: stimulation by intra-arterial and luminal guanylin and uroguanylin. Acta Physiol (Oxf) 2007; 191:309-317. Guanylins administered parenterally and luminally increased the rate of DBS, likely mediated by melatonin and cholinergic neurons.
44. Akiba Y, Mizumori M, Guth PH, et al. Duodenal brush border intestinal alkaline phosphatase activity affects bicarbonate secretion in rats. Am J Physiol Gastrointest Liver Physiol 2007; 293:G1223-G1233. IAP activity is determined by the rate of bicarbonate secretion and the luminal pH. Inhibiting IAP activity increases DBS. ATP is released into the duodenal lumen, where it is hydrolyzed by IAP activity, which in turn is dependent on local pH. As luminal ATP increases DBS via P2 receptors, IAP may serve as a surface pH sensor.
45. 2+, and PI3K-dependent signaling pathways.
46. 2/cAMP.
47. - secretion via a novel GC-C- and CFTR-independent pathway. FASEB J 2008; 22:1306-1316. Study on GC-C knockout mice determined that DBS could occur in a GC-C and CFTR independent manner.
48. Bengtsson MW, Makela K, Sjöblom M, et al. Food-induced expression of orexin receptors in rat duodenal mucosa regulates the bicarbonate secretory response to orexin-A. Am J Physiol Gastrointest Liver Physiol 2007; 293: G501-G509. Orexin-A activates peripheral orexin receptor 1 (OX1 ), thereby stimulating rat DBS.
49. Sasaki Y, Aihara E, Ise F, et al. Stimulatory effect of Coca-Cola on gastroduodenal, Inflammopharmacology 2007; 15:223-228. Coca-Cola and other carbonated beverages induced gastrointestinal bicarbonate secretion, likely mediated by carbonic anhydrase and endogenous prostaglandins.
50. Ohno T, Hattori Y, Komine R, et al. Roles of calcitonin gene-related peptide in maintenance of gastric mucosal integrity and in enhancement of ulcer healing and angiogenesis. Gastroenterology 2008; 134:215-225. CGRP in mice increased angiogenesis and ulcer repair.